Meril Life Sciences

The company claimed that at Rs 2 crore, MISSO is priced around 66 per cent lower than the available robotic knee replacement systems in the Indian market

Currently, 55 per cent of Meril's revenue comes from its international business, through its presence in over 150 countries and subsidiaries in more than 25 nations such as Germany, Russia and Brazil

Leading global growth investor Warburg Pincus has agreed to pick up a minority stake for USD 210 million (about Rs 1,575 crore) in Micro Life Sciences, the parent firm of the Meril Group, which is the largest medical devices firm in the country. Warburg said the transaction, awaiting CCI approval, will be carried out through its affiliate South Elm Investments. Founded by the Bilakhia family, Meril is a fast-growing medical devices firm that designs, manufactures and distributes clinically relevant and state-of-the-art medical devices. With R&D facilities, manufacturing capability, distribution reach, Meril has market leading position across several categories. Narendra Ostawal of Warburg Pincus India said he is excited by Meril's compelling growth story and believes it stands to benefit from the secular tailwinds of healthcare in the country. Sanjeev Bhatt of Meril said this investment establishes high degree of credibility to the domestic medical devices in the global landscape

Meril Life Sciences is first Indian firm to get nod for bio-resorbable cardiac scaffold